Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether the investigational drug
cetuximab, (Erbitux) alone or with paclitaxel (Taxol) can stabilize the growth of urothelial
cancer.